ArticleJournal of molecular histology2026
Anti-LCN2 antibody treatment is associated with attenuated hearing loss and blood-labyrinth barrier disruption in a mouse model of chronic kidney disease.
Ye Ding et al.PubMed ↗Publisher ↗
No numbers read from the abstract.